Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

Fourth Quarter and Full Year 2024 Results

Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.  

Thursday January 30, 2025
15:00 - 16:30 CET (9:00am – 10:30am EST)

Upcoming Events

18Mar

2025

Bernstein European Sustainability Conference Paris

08:00 - 15:00 CET (Paris)

Broker Conference


25Mar

2025

BNP Paribas Exane Healthcare Conference

08:00 Virtual

Broker Conference


26Mar

2025

Goldman Sachs Innovation Clinic Event

08:00 - 15:00 GMT (London)

Broker Conference


Press Releases


March 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

March 5, 2025
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

February 28, 2025
Media Update: AAD: new data advance Sanofi’s scientific leadership across innovative treatments for inflammatory skin diseases

Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Karine Roblot, wearing a light green protective suit, operating steel equipment with lots of valves, gauges and tubing
Karine Roblot, Vaccine Formulation Technician, Val de Reuil, France

2024 20-F

Presenting our 2024 FORM 20-F.

Subscribe to investor email alerts

Sign up to receive email alerts for various types of investor content

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com